Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Alzheimer's Rate Falling in the U.S.

The number of new cases of dementia has been declining in recent decades in the U.S., Germany, and other developed countries.

Restoring Memory via Implants

Two groups will lead a program to develop and test wireless, implantable devices to restore memory loss due to traumatic brain injury.

Cataract Surgery and Dementia Patients

Along with improving vision, cataract surgery may slow mental decline in people with Alzheimer's disease and other types of dementia.

Parkinsonism, ADHD: Genetic Link?

A genetic mutation has been linked to ADHD and may also cause parkinsonism in young people.

Advancement in Blood Test for Alzheimer's

A major advance has been made in creating a blood test to predict when at-risk people will develop Alzheimer's disease.

Sports Concussions: Ethical, Legal Issues

The ethical and legal issues surrounding evaluation, management of patients with sports-related concussions are addressed in a new position paper.

Wearable Exoskeleton for Paraplegia

The ReWalk Personal System has received FDA clearance for use at home and in the community for individuals with paraplegia.

Chart: Multiple Sclerosis Treatments

Review this new chart on multiple sclerosis treatments for quick information when you need it.

Videos

News

Could Mild TBI Symptoms Be PTSD?

Persistent symptoms lasting three months after mild traumatic brain injury (mTBI) do not represent postconcussion syndrome (PCS) and should be considered part of the hyperarousal dimension of posttraumatic stress disorder.

Status Epilepticus Therapy Granted Fast Track Status

The FDA has designated Fast Track status to SAGE-547 (SAGE Therapeutics) for the treatment of adult patients with refractory status epilepticus who have not responded to standard regimens.

Mislabeling Causes Ibuprofen, Oxcarbazepine Recall

American Health Packaging announced a voluntary recall of Ibuprofen Tablets 600mg and Oxcarbazepine Tables 300mg due to mislabeled inner unit dose blister packaging.

Fatty Acids May Prevent ALS

Amyotrophic lateral sclerosis (ALS) may be delayed or prevented with the consumption of foods high in ω-3 polyunsaturated fatty acids (PUFAs).

FEATURES

Numbness, Tingling, Weakness, and Coolness in a 'Jammed' Hand

Numbness, Tingling, Weakness, and Coolness in a 'Jammed' Hand

A man tells the orthopedics clinic staff about odd sensations in his hand a week after a car accident.

Could Mild TBI Symptoms Be PTSD?

Could Mild TBI Symptoms Be PTSD?

Persistent symptoms lasting three months after mild traumatic brain injury (mTBI) do not represent postconcussion syndrome (PCS) and should be considered part of the hyperarousal dimension of posttraumatic stress disorder.

Status Epilepticus Therapy Granted Fast Track Status

The FDA has designated Fast Track status to SAGE-547 (SAGE Therapeutics) for the treatment of adult patients with refractory status epilepticus who have not responded to standard regimens.

Featured courses from mycme

A 70-Year-Old Woman With Altered Cognition and Emotional LabilityExternal web site

Several illnesses may cause dementia, including dementia with Lewy bodies (DLB), Pick’s disease and other ...

CME 0.50 Credits

MS: Focus on Neurodegeneration and NeuroprotectionExternal web site

This CME-certified roundtable discussion enables learners to strengthen their knowledge of the potential neuroprotective strategies ...

CME 1.25 Credits

Re-examining the Role of Interferon in Treating Multiple SclerosisExternal web site

This CME/CE-certified activity focuses on the optimal management of multiple sclerosis with an emphasis on ...

CME|CE 1.00 Credits

Sign Up for Free e-newsletters